Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hinge Health, Inc. Class A ( (HNGE) ) just unveiled an announcement.
Hinge Health, Inc. recently completed its initial public offering (IPO) of Class A common stock, during which directors, executive officers, and other key stakeholders entered into lock-up agreements restricting the sale of shares for up to 180 days post-IPO. On August 6, 2025, the company met conditions allowing for an early release of 1.66 million shares from these restrictions, enabling their sale starting August 19, 2025, while the remaining shares remain under lock-up.
The most recent analyst rating on (HNGE) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on Hinge Health, Inc. Class A stock, see the HNGE Stock Forecast page.
Spark’s Take on HNGE Stock
According to Spark, TipRanks’ AI Analyst, HNGE is a Neutral.
Hinge Health, Inc. demonstrates strong revenue growth and effective cost management, which are significant strengths. However, the lack of profitability and negative P/E ratio are major concerns. The stock’s bullish momentum is tempered by overbought signals, and while corporate events show positive strategic momentum, the overall financial health and valuation remain critical areas for improvement.
To see Spark’s full report on HNGE stock, click here.
More about Hinge Health, Inc. Class A
Average Trading Volume: 1,071,452
Current Market Cap: $4.25B
See more data about HNGE stock on TipRanks’ Stock Analysis page.